CELLPURICS
CELLPURICS
The in vitro efficacy evaluation service of CellPurics is provided by expert researchers using state-of-the-art equipment to quickly
and accurately evaluate the safety and efficacy of test substances.
It provides customers with reliable data that they need for drug discovery and safety assessment.
We evaluate the efficacy of in vitro cancer immunotherapy through various immunological analyses and experiments using cells.
Complement-dependent Cell-Mediated Cytotoxicity (CDCC) Testing
Antibody-dependent Cell-mediated Cytotoxicity (ADCC) Testing
T cell-mediated tumor cell killing assays
NK cell-mediated tumor cell killing assays
Immune cell Characterization
Cell proliferation
Cytokine release
Activation marker expression
Exhaustion marker expression
Co-inhibitory Bioassays
(PD-1, CTLA-4, LAG-3, TIGIT, CD226)
Co-stimulatory Bioassays
(GITR, 4-1BB, OX40, CD40,HVEM)
Combination Bioassay (PD-1+TIGIT)